He wants to run a Phase 2b dosing and once-a-day extended release?
Test out a Z160 + Exalgo combo to dissociate the hydromorphone for cancer related pain?
Test out other possible blockbuster Z160 indications, the holy grail, migraines?
Or is the delay simply estimated partnership and cash delays into Phase 3?
Or, this is a normal timeline for a large, multi-center phase 3?
Finally got it on the last try. Major phase III studies take time to design. If they are smart they will also submit the trial design to the FDA for approval, which all but guarantees drug approval upon successful completion. Sorry, but nothing moves that fast in the world of new drug development. But don't worry. If phase II results are really good, it will still be a very good yeR for Zalicus and it's investors.